INTRODUCTION
[Lines 67-69] Include the potential effect of the other B-family vitamins, since in the study used as reference the best results came from folate.
METHODS:
[Lines 103 -104] I would like to know whether it was assessed the presence of diseases that could affect intestinal absorption or liver and kidney function? Did the authors check if there was any participant in dialysis or with renal failure?
[Line 110] Please, correct the unit of measurement of height in BMI. It is m2 and not cm2 as described.
[Lines 113-117] Why it was evaluated L2-L4 and not L1-L4? Additionally, hip (femoral neck) is another important site of investigation of osteoporosis and it is related to the worst fractures. Thus, why this site was not assessed? Please, provide a rationale.
[Lines 119 -122] The diagnosis of osteoporosis include the -2.5, so those with T-score =-2.5 should be included in the osteoporosis group and not in the osteopenia group. Please, check if it was just a type error or if it is not properly grouped in the database. Correct this description in the manuscript and, please, include the signal "minus" before the 2.5 (it is missed).
[Lines 164-168] The authors did not mention in which category those with osteopenia were placed. Please, clarify in the description.
RESULTS
Please, provide the range values for Vit B-6 in entire population and for women and men.
[Lines 174-179] I suggest to place this paragraph in the methods section. Additionally, did the authors check the use of medications that could affect vitamin B-6 absorption, like laxatives? Did "Hormone drugs" include hormonal replacement therapy? Please, include in the description.
[ According to the Table 2 , VitB-6 in the osteoporosis group was higher than the normal group, but lower than the osteopenia group. However, such difference is minimal, and I do not believe that could clinically mean anything. Tables 3 & 4 : Did the authors check to control the models for 25(OH)D and/or PTH?
Results from
Results from Table 5: Simple correlations only suggest some association, but it seems that the results are a bit random. Vit-B6 has a weak negative correlation with both formation and resorption biomarkers. What exactly that mean? Were all the variables normally distribute? Please, provide the scatterplots to confirm that there were no outliers for the variables with relevant results.
I suggest to perform linear regression models with the BMD or T-scores as dependent and 25(OH)D/PTH, and Vit B-6 as independents to evaluate if the association of B-6 is VD/PTH dependent.
DISCUSSION
[Line 289] Please, change "old people" for "older people".
[ This phrase is overstated, since it is based in the results of only 2 observational studies which don't provide any causal effects.
[Lines 295-302] I do believe that this paragraph is also overstated. There are other variables that can be influencing the results, as the 25(OH)D, since the women were deficient. Other variables that the authors did not assess, as diet and physical activity could also change the results, considering the 95%CI was marginally significant.
[Lines 318-342] This section discuss only about the relationship between estrogen and vit B-6, but in this study, only postmenopausal women were included and estrogen concentrations were not assessed; thus, the discussion is not pertinent. I would like that this section have included some about vit B-6 been inversely correlated with both markers of bone formation and resorption. May that mean that B-6 can also increase bone resorption? There is anything about it in the literature?
[Lines 359-362] As the phosphorylation of Vit B-6 occurs in the liver (as the 25OHD), do the authors think this could explain any VD and B6 interplay? And what if the impact of B-6 is not direct on bone, but on VD (an indirect impact). I think this part of the discussion could be improved.
Strengths and Limitations: The authors did not assess other variables with potential impact on bone, as dietary intake and physical activities. Other sites for osteoporosis diagnosis were not assessed (only lumbar spine). Please include as a limitation.
REVIEWER
JOSÉ OTÁVIO DO AMARAL CORRÊA FEDERAL UNIVERSITY OF JUIZ DE FORA -BRAZIL REVIEW RETURNED 17-Jan-2019
GENERAL COMMENTS
In line 126 was written: "The serum was immediately stored and stored at 4 ℃" How long was the serum stored until the titers were taken? Insert this information in the article.
Although there are already many studies were conducted in Western populations, these data are scarce in Asian populations. The survey was conducted in a clear and objective manner. Unless I have a better judgment, I consider it appropriate for publication.
REVIEWER

Jian Dong
Fudan university Zhongshan Hospital REVIEW RETURNED 15-Feb-2019
GENERAL COMMENTS
The authors conducted a cross-sectional study design and draw the conclusion that a relatively low serum Vit B-6 concentration is a risk factor for osteoporosis in postmenopausal women, including those with normal serum Vit B-6 concentrations.
In the study, the Inclusion and exclusion criteria has not been well described BMD in the total lumbar was affected by the osteophte. There was a serious bias in this analysis by means of the lumbar BMD. The authors stated that "The associations between Vit B-6 values and ranks of lumbar BMD (rank 0, normal, T-scores ≧ 1.0; rank 1, osteopenia, −2.5 < T-scores < −1; rank 2, osteoporosis, Tscores ≦ 2.5) were analysed using linear regression." Here ranks of lumbar BMD only takes three values. Have the authors checked the model normality assumption? Is one-way ANOVA better in this case? 3.
REVIEWER
Because of three levels of ranks of osteoporosis, should ordered logistic model instead of logistic regression model be used?
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1 GENERAL COMMENTS: 1) I recommend to use "older adults" or "older persons/people" than "elderly" in the title and in entire manuscript, as recommended in https://www.ncbi.nlm.nih.gov/pubmed/29704926. Reply: Thank you for your suggestion. We have replaced "elderly people" with "older people" in entire manuscript.
2) Please, provide the exactly p-value in the results section. Reply: Thank you for your suggestion. The exactly p-values in the results section were provided.
Abstract: The objective stated in the abstract differs from the objective in the body of the manuscript and is not appropriate since the authors did not evaluate the effect of B6 deficiency longitudinally. I suggest removing the first part "To determine the effects…and". Additionally, the authors did not evaluate the relationship between B-6 and BMD, but yes the B6 and the status of BMD. Please, correct this in the abstract and in the manuscript to suit better. Reply: Yes, we didn't evaluate the relationship between B-6 and BMD, but the relationship between serum B-6 and the status of BMD. The abstract nd relative contents of the manuscript were revised.
INTRODUCTION
[Lines 67-69] Include the potential effect of the other B-family vitamins, since in the study used as reference the best results came from folate. Reply: Thank you for your suggestion. The potential effects of other B-family vitamins were included. "The Vitamin B family includes thiamine (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), pyridoxine (B6), biotin (B7), folic acid or folate (B9) and cobalamin (B12). Low levels of Vitamin B12 and folate have beenproved to be associated with low bone mineral density (BMD) and a higher risk of fractures in the elderly." METHODS:
[Lines 103 -104] I would like to know whether it was assessed the presence of diseases that could affect intestinal absorption or liver and kidney function? Did the authors check if there was any participant in dialysis or with renal failure? Reply: Thank you for your suggestion. We did exclude participants with physical diseases that affect bone metabolism or gastrointestinal absorption including chronic diarrhea, severe liver dysfunction or renal failure(includes participants in dialysis), gastrectomy and enterectomy. Those taking medicines that affect bone metabolism or serum Vitamin B6 level were also excluded including vitamin B or multivitamin supplements, hormone drugs and antiosteoporosis drugs.
The description in the methods section has been revised.
Reply: Sorry for the mistake. It has been corrected.
[Lines 113-117] Why it was evaluated L2-L4 and not L1-L4? Additionally, hip (femoral neck) is another important site of investigation of osteoporosis and it is related to the worst fractures. Thus, why this site was not assessed? Please, provide a rationale. Reply: Actually we did measure L1-L4 BMD, but wrote L2-L4 by mistake. It has been corrected in the manuscript. We totally agree that hip (femoral neck) is another important site of investigation of osteoporosis. As mentioned in the manuscript, the present study was a cross-sectional study within the framework of an ongoing prospective population-based cohort study. For the sake of economic cost and limited time for on-site investigation, only lumbar spine BMD was measured according to the reference which concluded that if a scan were to be repeated, it would be of the spine because it is the site of rapid bone loss [Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women's Health Initiative study. Menopause, 2015, 22(6):58-583] [Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis. JAMA, 1941 JAMA, , 116: 2465 JAMA, -2474 . We have added the reasons in the methods section. This is also one of the limitations of our study, which was listed in the Strengths and limitations section.
[Lines 119 -122] The diagnosis of osteoporosis include the -2.5, so those with T-score =-2.5 should be included in the osteoporosis group and not in the osteopenia group. Please, check if it was just a type error or if it is not properly grouped in the database. Correct this description in the manuscript and, please, include the signal "minus" before the 2.5 (it is missed). Reply: Sorry for the mistakes. Actually patients with T-score = -2.5 were also included in the osteoporosis group. It has been revised.
Reply: Thank you for your reminding. In order examine the associations between the Vit B-6 concentration quartiles and risk of osteoporosis, only normal controls and participants with osteoporosis, but not those with osteopenia, were included for analysis with a logistic regression model.
RESULTS
Please, provide the range values for Vit B-6 in entire population and for women and men. Reply: Thank you for your instructive suggestions. The range values for Vit B-6 were provided as table 2.
[Lines 174-179] I suggest to place this paragraph in the methods section. Additionally, did the authors check the use of medications that could affect vitamin B-6 absorption, like laxatives? Did "Hormone drugs" include hormonal replacement therapy? Please, include in the description. Reply: Thank you for your suggestions. The paragraph has been moved to the methods section. We only checked the use of vitamin supplements, hormone drugs and antiosteoporosis drugs, but not medicines that could affect vitamin B-6 absorption. This is also one of the limitations of our study, which was discussed in the Strengths and limitations section. "Hormone drugs" include hormonal replacement therapy, and it was emphasized in the Methods part.
[ According to the Table 2 , VitB-6 in the osteoporosis group was higher than the normal group, but lower than the osteopenia group. However, such difference is minimal, and I do not believe that could clinically mean anything. Reply: We totally agree with you that it might be meaningless clinically and the sentence has been revised. "The overall serum Vit B-6 concentrations in the control, osteopenia and osteoporosis groups were similar in both man and women, though there were limited statistical significances between the osteoporosis group and other two groups in the women." Results from Table 5 : Simple correlations only suggest some association, but it seems that the results are a bit random. Vit-B6 has a weak negative correlation with both formation and resorption biomarkers. What exactly that mean? Were all the variables normally distribute? Please, provide the scatter plots to confirm that there were no outliers for the variables with relevant results. Reply: Thank you. We have added the discussion about the relationship between Vit B-6 and bone turnover markers in the discussion section.
The scatter plots were provided as supplementary figures (Fig. S1 and Fig. S2 ). The variables normally distributed, but in order to reveal a complete description of the association, we used Pearson's correlationanalysis to reveal the relationship between serum Vit B6 concentration and bone turnover markers. [ This phrase is overstated, since it is based in the results of only 2 observational studies which don't provide any causal effects. Reply: Sorry for making confusion. Actually one of the studies was a longitudinal follow-up study of the Framingham Osteoporosis Study. We have removed another study from the discussion and revised the paragraph.
[Lines 295-302] I do believe that this paragraph is also overstated. There are other variables that can be influencing the results, as the 25(OH)D, since the women were deficient. Other variables that the authors did not assess, as diet and physical activity could also change the results, considering the 95%CI was marginally significant. Reply: Thank you. We totally agree with you that there are other variables that can be influencing the results such as the 25(OH)D, PTH, dietary intake and physical activity. The paragraph has been revised and the limitations were also listed.
[Lines 318-342] This section discuss only about the relationship between estrogen and vit B-6, but in this study, only postmenopausal women were included and estrogen concentrations were not assessed; thus, the discussion is not pertinent. I would like that this section have included some about vit B-6 been inversely correlated with both markers of bone formation and resorption. May that mean that B-6 can also increase bone resorption? There is anything about it in the literature? Reply: Thank you for your suggestions. We have rewritten this section to lessen the discussion of the relationship between estrogen and Vit B-6, and add the discussion of Vit B-6 and bone turnover markers. "Low concentration of Vit B-6 has been demonstrated a stimulatory effect on osteoclast activity, though no significant effect on osteoclast number was revealed. In addition, homocysteine (HCY) has been confirmed a significant correlation with bone resorption markers. High HCY level induced by low Vit B-6 concentration, could stimulate bone resorption, leading to a shift of bone metabolism towards bone resorption. This is consistent with our finding that the serum Vit B-6 concentration was inversely associated with the concentration of bone resorption marker. Only A few studies have reported the relationship between serum Vit B-6 and bone formation markers with equivocal results. Holstein found that the concentrations of serum OST were significantly lower in individuals with low serum Vit B-6 concentrations than in those with high serum Vit B-6 concentrations. Also plasma OST and bone specific ALP activity were significantly decreased in Vit B-6 deficient-animals. In contrast, in vitro study with human primary osteoblasts found that decreasing B-vitamin concentrations was not accompanied by changes of AP, osteocalcin, PINP as well as mineralized matrix formation. It was reported that a decrease in bone resorption results in a rapid reduction in bone formation because of reduced release of coupling factors. Therefore, there was possibly an indirect effect of serum Vit B-6 on bone formation, which is secondary to its regulation on bone resorption." As the phosphorylation of Vit B-6 occurs in the liver (as the 25OHD), do the authors think this could explain any VD and B6 interplay? And what if the impact of B-6 is not direct on bone, but on VD (an indirect impact). I think this part of the discussion could be improved. Reply: Thank you very much for your instructive suggestions. We have searched relative references and only found the possible regulation of Vit B-6 on Vit D metabolism. Not yet studies have proposed an effect of Vit D on Vit B-6 metabolism. Nevertheless, the idea is really an interesting one which deserves further investigations.
Since serum Vit B-6 might regulate Vit D metabolism, it was inferred that Vit B-6 might regulate bone metabolism at least partially through its regulation on Vit D, which has dual effects on both bone formation and bone resorption. To address this issue, the corresponding part of Discussion section has been revised.
Strengths and Limitations:
The authors did not assess other variables with potential impact on bone, as dietary intake and physical activities. Other sites for osteoporosis diagnosis were not assessed (only lumbar spine). Please include as a limitation. Reply: Thank you very much for your suggestions. We have revised the Strengths and Limitations section.
Reviewer: 2 Please leave your comments for the authors below In line 126 was written: "The serum was immediately stored and stored at 4 ℃" How long was the serum stored until the titers were taken? Insert this information in the article. Response: Thank you for your suggestion. We have added relative information in the Methods section. "The serum samples were collected within 2 h after the blood collection. The blood was gently mixed and centrifuged at 3000 rpm for 15 min at room temperature to separate the serum. The serum was immediately stored at 4℃ and was tested within 24 h." Although there are already many studies were conducted in Western populations, these data are scarce in Asian populations. The survey was conducted in a clear and objective manner. Unless I have a better judgment, I consider it appropriate for publication. Reply: Thank you for your recognition of our work.
Reviewer: 3
In the study, the Inclusion and exclusion criteria has not been well described BMD in the total lumbar was affected by the osteophte. There was a serious bias in this analysis by means of the lumbar BMD. Reply: Thank you for your suggestion. The inclusion and exclusion criteria section was modified. We totally agree that hip (femoral neck) is another important site of investigation of osteoporosis. As mentioned in the manuscript, the present study was a cross-sectional study within the framework of an ongoing prospective population-based cohort study. For the sake of economic cost and limited time for on-site investigation, only lumbar spine BMD was measured according to the reference which concluded that if a scan were to be repeated, it would be of the spine because it is the site of rapid bone loss [Bone mineral density measurements: how often should bone mineral density be measured in postmenopausal women? Results from the Women's Health Initiative study. Menopause, 2015, 22(6) :581-583] [Albright F, Smith PH, Richardson AM. Postmenopausal osteoporosis. JAMA, 1941 JAMA, , 116: 2465 JAMA, -2474 . We have added the reasons in the methods section. This is also one of the limitations of our study, which was discussed in the strengths and limitations section and discussion section.
-I suggest to present the content of the table 2 in the text only. And please, consider the distribution of the variable to describe it properly. Suggestion (e.g) : The mean/median of B6 in entire population was (the value in mean and SD OR in median and interquartile range), with men showing XX values and women YY. Please leave your comments for the authors below The paper has improved after the first revision.
However there are 2 main things that I believe that are important to consider before accepting for publication. 1) There are some English/type errors. So, I think that would better to read it again more carefully.
2) The discussion has improved, but for me is a little bit confusing in the way it is organized (topic order).
Reply: Sorry for the mistakes. We have read the manuscript carefully, and made corrections.
For the discussion section, at first, we put forward the most important finding of our study that a relatively low serum Vit B-6 concentration, even in the normal range, may be a risk factor for osteoporosis in postmenopausal women. And also we discussed the similarities and differences between our findings and those of other studies.
Then we further talked about the relationship between serum vit B-6 concentration and bone turnover markers, Vitamin D and PTH, and discussed the possible reasons for the relationships.
Other minimal changes required are: -In the statistics section, in the topic about ANOVA/Kruskal-Wallis, it is important to mention that the groups (normal, osteopenia and osteoporosis) were compared according to the gender.
